logo

Last Update

This profile was last updated on 7/29/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Dave Amerson?

Dave Amerson

President and Chief Executive Officer

NeoTract Inc

HQ Phone:  (925) 401-0700

Direct Phone: (925) ***-****direct phone

Email: d***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

NeoTract Inc

4473 WILLOW RD

Pleasanton, California,94588

United States

Company Description

NeoTract, Inc. is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. The company's initial focus is on improving the standard of care for patients with BPH using the UroLift...more

Background Information

Employment History

General Manager for the Surgical Urology Division

Coloplast Corp


Affiliations

EMKinetics

Board Member


The Urology Society of America

Board Member


American Lithotripsy Society

Board Member


Education

B.A.

Political Science

University of West Georgia


M.B.A.

Argosy University


Web References(100 Total References)


NeoTract's UroLift® Implant Procedure for Men with Enlarged Prostate Receives Medicare and Medicaid Outpatient Billing Codes for Reimbursement | UroLift

urolift.com [cached]

"Having defined coding for the UroLift System will greatly facilitate the reimbursement process," said Dave Amerson, President and CEO, NeoTract.


UroLift® System | NeoTract, Inc. Board of Directors

urolift.co.uk [cached]

Dave Amerson - President and CEO, NeoTract, Inc.
Dave is President and CEO of NeoTract, Inc., a medical device company focused on shifting the treatment paradigm in urology. Under his leadership, NeoTract received FDA De Novo clearance for the UroLift® System, a minimally invasive technology to treat symptoms of benign prostatic hyperplasia (BPH). He also led the company to achieve critical reimbursement milestones, including new CPT 1 codes, a New Tech APC code and a national coverage policy by Aetna for the UroLift System. Internationally, NeoTract has achieved positive NICE guidance for the UroLift System in the UK and a prosthesis code with payment for the UroLift implant in Australia. Dave joined NeoTract in 2011, bringing over 25 years of management experience in the medical device field with an emphasis in urology. Prior to NeoTract, Dave was Global Vice President; General Manager for the Coloplast Surgical Urology division. Dave began his career at Osbon Medical Systems. He is a former board member of the Urology Society of America, the American Lithotripsy Society and EMKinetics. Dave holds an M.B.A. from Argosy University and a B.A. in Political Science from the University of West Georgia.


First U.S. Patient Treated Following FDA Clearance of NeoTract's UroLift® System | UroLift

urolift.com [cached]

"We, at NeoTract, are extremely pleased to bring our straightforward, innovative UroLift System to physicians and patients in selected U.S. centers," commented Dave Amerson, president and CEO of NeoTract.


NeoTract, Inc. Announces Excellent Data From Two Studies of the Minimally Invasive UroLift System Treatment for Enlarged Prostate | UroLift

urolift.com [cached]

"These results confirm the long-term benefits of the UroLift System and show that it is a compelling alternative to the procedure that has been the standard of care for decades," said Dave Amerson, president and CEO, NeoTract.


NeoTract Receives Phoenix 2016 Most Promising New Product Award for UroLift® Device for Enlarged Prostate | UroLift

urolift.com [cached]

"It is very gratifying to be recognized by the Phoenix Conference organizers and conference attendees, leaders who have developed many breakthroughs that have revolutionized the treatment of a wide variety of conditions," said Dave Amerson, President and CEO of NeoTract.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory